Symptoms and treatment response to florensocatib and inhaled tobramycin in bronchiectasis: Post hoc analysis of two randomized trials

Yong-Hua Gao, Xue-Shan Li, Xiao-Li Sun, Fang-Qiong Li, Lu-Yin Sun, Han-Mo Liu, Wei-Jie Guan · 2026

Read Symptoms and treatment response to florensocatib and inhaled tobramycin in bronchiectasis: Post hoc analysis of two randomized trials by Yong-Hua Gao, Xue-Shan Li, Xiao-Li Sun, Fang-Qiong Li, Lu-Yin Sun, Han-Mo Liu, Wei-Jie Guan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13589483.txt.

Description

Yong-Hua Gao and co-authors re-read two trials to ask whether symptom load foretells who gains from bronchiectasis drugs. The airway disease brings daily cough and flare-ups. Their 2026 analysis pools a pill trial and an inhaled antibiotic trial, with 224 and 357 patients. A standard symptom scale sorts patients by burden at the start. Treatment effects are then read within each burden band.

The pill cut flare-ups by over half overall, with gains in both bands but no symptom lift. The inhaled drug lifted symptom scores past the meaning threshold in high-burden patients. Its gains grew with burden. The team casts burden as a cheap sorting tool: heavy symptoms may mark who needs the germ-fighting route most.

Catalog record

CREATORYong-Hua Gao, Xue-Shan Li, Xiao-Li Sun, Fang-Qiong Li, Lu-Yin Sun, Han-Mo Liu, Wei-Jie Guan
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13589483

Browse the full library · About the Tower of Babel